Disseminated superficial actinic porokeratosis

K. S. Dhillon, Deepak Sharma, Tarunveer Singh, Sweksha Srivasatva, Ritika Srivastava, Areeba Khan, Soni Yadav, Vidhi Agarwal

Abstract


Disseminated Superficial Actinic Porokeratosis (DSAP) is a type of porokeratosis observed in parts of the skin exposed to intense sunlight and usually appears in the third or fourth decade of life. We are presenting a case report of a 30 year old male patient presenting with multiple lesions over the face and limbs. 


Keywords


Porokeratosis, Skin, Multiple lesions, Face and limbs

Full Text:

PDF

References


Wolff-Schreiner EC. Porokeratosis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, Goldsmith LA, et al., eds. Dermatology in general medicine. 5th ed. New York: McGraw-Hill Book Company; 1999: 624-630.

Kang BD, Kye YC, Kim SN. Disseminated superficial actinic porokeratosis with both typical and prurigo nodularis-like lesions. J Dermatol. 2001;28:81-5.

Kaur S, Thami GP, Mohan H, Kanwar AJ. Co-existence of variants of porokeratosis: a case report and a review of the literature. J Dermatol. 2002;29:305-9.

Holmes G, Sidhu S, Wakelin SH, Orton D, Marren P. Disseminated superficial actinic porokeratosis occurring in two members of an Asian family. Clin Exp Dermatol. 1997;22:280-2.

Ramesh V, Misra RS, Mahaur BS. Pseudoainhum in porokeratosis of Mibelli. Cutis. 1992 Feb;49(2):129-30.

James WD, Rodman OG. Squamous cell carcinoma arising in porokeratosis of mibelli. Int J Dermatol. 1986 Jul-Aug;25(6):389-91.

Sasson M, Krain AD. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg. 1996 Apr;22(4):339-42.

Seishima M, Izumi T, Oyama Z, Maeda M. Squamous cell carcinoma arising from lesions of porokeratosis palmaris et plantaris disseminata. Eur J Dermatol. 2000 Aug;10(6):478-80.

Otsuka F, Umebayashi Y, Watanabe S, Kawashima M, Hamanaka S. Porokeratosis large skin lesions are susceptible to skin cancer development: histological and cytological explanation for the susceptibility. J Cancer Res Clin Oncol. 1993;119(7):395-400.

Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol. 1994 Feb;130(2):187-90.

Ninomiya Y, Urano Y, Yoshimoto K, Iwahana H, Sasaki S, Arase S. p53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma. J Dermatol Sci. 1997 Mar;14(3):173-8.

Sasaki S, Urano Y, Nakagawa K, Nagae H, Nakanishi H, Arase S. Linear porokeratosis with multiple squamous cell carcinomas: study of p53 expression in porokeratosis and squamous cell carcinoma. Br J Dermatol. 1996 Jun;134(6):1151-3.

Urano Y, Sasaki S, Ninomiya Y, Oura H, Arase S. Immunohistochemical detection of p53 tumor suppressor protein in porokeratosis. J Dermatol. 1996 May;23(5):365-8.

Arranz-Salas I, Sanz-Trelles A, Ojeda DB. p53 alterations in porokeratosis. J Cutan Pathol. 2003 Aug;30(7):455-8.

Chernosky ME, Anderson DE. Disseminated superficial actinic porokeratosis. Clinical studies and experimental production of lesions. Arch Dermatol. 1969;99(4):401-7.

Auslaender S, Barzilay A, Trau H. Porokeratosis of the skin in an immunosuppressed patient. Harefuah. 1994;127(9):303-5.

Jih MH. Porokeratosis plantaris, palmaris, et disseminata. Dermatol Online J. 2003;9(4):34.

Ibbotson SH. Disseminated superficial porokeratosis: what is the association with ultraviolet radiation? Clin Exp Dermatol. 1996;21(1):48-50.

Lederman JS, Sober AJ, Lederman GS. Psoralens and ultraviolet A, immunosuppression, and porokeratosis. J Am Acad Dermatol. 1986;14(2 Pt 1):284-5.

James AJ, Clarke LE, Elenitsas R, Katz K. Segmental porokeratosis after radiation therapy for follicular lymphoma. J Am Acad Dermatol. 2008;58(2 Suppl):S49-50.

Romani J, Pujol RM, Casanova JM, de Moragas JM. Disseminated superficial porokeratosis developing after electron-beam total skin irradiation for mycosis fungoides. Clin Exp Dermatol. 1996;21(4):310-2.

Zhang ZH, Niu ZM, Huang W, Xiang LH, Gu CY, Yang L, et al. Loss of heterozygosity on chromosome 12q in disseminated superficial actinic porokeratosis. J Invest Dermatol. 2007;127(2):482-5.

Danno K, Yamamoto M, Yokoo T, Ohta M, Ohno S. Etretinate treatment in disseminated porokeratosis. J Dermatol. 1988;15:440.

Otsuka F, Umebayashi Y, Watanabe S, Kawashima M, Hamanaka S. Porokeratosis large skin lesions are susceptible to skin cancer development: histological and cytological explanation for the susceptibility. J Cancer Res Clin Oncol. 1993;119:395.